These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 3829224)
21. [Retinopathy due to ionizing radiation, clinical aspects]. Dumoulin-Wibail C; Toussaint D; Dumoulin P Bull Soc Belge Ophtalmol; 1982; 199-200():43-53. PubMed ID: 7182057 [No Abstract] [Full Text] [Related]
22. [Fluorographic aspect of papillo-retinal edema due to hypotonia]. Turut P; François P; Dufour D; Woillez M Bull Soc Ophtalmol Fr; 1974 Apr; 74(4):486-92. PubMed ID: 4468151 [No Abstract] [Full Text] [Related]
23. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier. Sander B; Larsen M; Moldow B; Lund-Andersen H Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):433-8. PubMed ID: 11157879 [TBL] [Abstract][Full Text] [Related]
24. Nature and clinical application of human electroretinogram La-wave. Kaban AA; Shcherbatova OI Med Prog Technol; 1992; 18(1-2):73-8. PubMed ID: 1388237 [No Abstract] [Full Text] [Related]
25. [The influence of retinal argon laser photocoagulation on results of vitreous fluorophotometry in patients with diabetic retinopathy]. Gierek-Lapińska A; Formińska-Kapuścik M; Janiec S; Rzendkowski M Klin Oczna; 1994; 96(8-9):263-4. PubMed ID: 7897990 [TBL] [Abstract][Full Text] [Related]
26. Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry. Schalnus R; Ohrloff C; Jungmann E; Maass K; Rinke S; Wagner A Ger J Ophthalmol; 1993 Aug; 2(4-5):202-6. PubMed ID: 8220099 [TBL] [Abstract][Full Text] [Related]
27. Calcein fluorophotometry in streptozocin-induced diabetic rats. Golshani MR; Khoobehi B; Peyman GA; Aras C Ophthalmic Surg; 1994 Aug; 25(8):526-31. PubMed ID: 7970535 [TBL] [Abstract][Full Text] [Related]
28. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study. Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM Retina; 1995; 15(2):134-40. PubMed ID: 7624601 [TBL] [Abstract][Full Text] [Related]
34. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957 [TBL] [Abstract][Full Text] [Related]
35. [Diabetic retinopathy in its advanced stages]. Rousselie F Journ Annu Diabetol Hotel Dieu; 1971 May; 12(0):201-8. PubMed ID: 4950782 [No Abstract] [Full Text] [Related]
37. [Fluorophotometry and the Fluorotron]. Menerath JM; Solé P Bull Soc Ophtalmol Fr; 1984 Dec; 84(12):1467-71. PubMed ID: 6544674 [No Abstract] [Full Text] [Related]
38. [Electrodiagnosis of retinal diseases (retinal rest and action potentials]. François J; de Rouck A; Combie E; Zanen A Bull Soc Belge Ophtalmol; 1974 Jan; 166(1):1-494. PubMed ID: 4361629 [No Abstract] [Full Text] [Related]
39. Fluorescein retinal angiography as an aid in ocular diagnosis. Edwards EC; Barbee JY; MacDonald R; Van Cader T J Ky Med Assoc; 1969 Mar; 67(3):185-90. PubMed ID: 5774123 [No Abstract] [Full Text] [Related]
40. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]